Adjuvant Therapy in the Management of Osteosarcoma: Need for Critical Reassessment

  • K. Breur
  • E. van der Schueren
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 68)


Until about 8 years ago, the prognosis for patients with osteosarcomas used to be extremely bad [3, 9, 14] in spite of the fact that the control of the primary tumor is usually achieved. As about 90% of these tumors arise in the long bones of the limbs, ablative surgery can usually be performed as a radical procedure and local recurrences are fairly rare. In some centers, mainly in France, radiotherapy is used as an alternative. As osteosarcomas are rather radioresistant tumors, very high radiation doses are necessary. Even though such treatment regimens sometimes lead to complications in the normal tissues, some local recurrences still do occur. However, both the sequelae and the tumor regrowth can usually be managed without great difficulty with ablative surgery. Although this policy is much more complicated and requires intensive follow-up of the patient, the possibility to preserve the limb in a fraction of the patients merits serious consideration.


Adjuvant Therapy Lung Metastasis Appearance Rate Irradiate Patient Ablative Surgery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Breur, K., Cohen, P., Schweisguth, O., Hart, A. M. M.: Irradiation of the lungs as an adjuvant therapy of osteosarcoma of the limbs. E.O.R.T.C. randomized study. Eur. J. Cancer 14, 461–471 (1978).PubMedCrossRefGoogle Scholar
  2. 2.
    Burchenal, J. H.: A giant step forward — if......N. Engl. J. Med. 291, 1029–1031 (1974).CrossRefGoogle Scholar
  3. 3.
    Cohen, P.: Osteosarcoma of the long bones. Eur. J. Cancer, (in press) (1978).Google Scholar
  4. 4.
    Cortes, E. O., Holland, J. F., Glidewell, O.: Amputation and adriamycin in primary osteosarcoma: A 5-year report. Cancer Treat. Rep. 62, 271–277 (1978).PubMedGoogle Scholar
  5. 5.
    Cortes, E. P., Holland, J. F., Wang, J. J., Sinks, L. F.: Doxorubicin in disseminated osteosarcoma. JAMA 221, 1132–1138 (1972).CrossRefGoogle Scholar
  6. 6.
    Dahlin, D., Coventry, M.: Osteogenic sarcoma: A study of 600 cases. J. Bone Joint Surg. A 49, 101–110 (1967).Google Scholar
  7. 7.
    Etcubanas, E., Wilbur, J. R.: Adjuvant chemotherapy for osteogenic sarcoma. Cancer Treat. Rep. 62, 283–298 (1978).PubMedGoogle Scholar
  8. 8.
    Fossati Bellani, F., Gasparini, M., Gennari, L., Fontanillas, L., Bonadonna, G.: Adjuvant treatment with adriamycin in primary operable osteosarcoma. Cancer Treat. Rep. 62, 279–281 (1978).Google Scholar
  9. 9.
    Friedman, M. A., Carter, S. K.: The therapy of osteogenic sarcoma: Current status and thoughts for the future. J. Surg. Oncol. 1, 482–510 (1972).CrossRefGoogle Scholar
  10. 10.
    Jaffe, N.: Recent advances in the chemotherapy of metastatic osteogenic sarcoma. Cancer 30, 1627–1631 (1972).PubMedCrossRefGoogle Scholar
  11. 11.
    Jaffe, N., Frei, E. III, Traggis, D., Bishop, Y.: Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. N. Engl. J. Med. 291, 994–997 (1974).PubMedCrossRefGoogle Scholar
  12. 12.
    Jaffe, N., Frei, E. III, Watts, H., Traggis, D.: High-dose methotrexate in osteogenic sarcoma: A 5-year experience. Cancer Treat. Rep. 62, 259–264 (1978).PubMedGoogle Scholar
  13. 13.
    Jeffree, G. M., Price, D. H. G., Sissons, H. A.: The metastatic patterns of osteosarcoma. Br. J. Cancer 32, 87–107 (1975).PubMedCrossRefGoogle Scholar
  14. 14.
    Marcove, R. C., Mike, V., Hajek, J. V., Levin, A. G., Butter, R. V. P.: Osteogenic sarcoma, under the age of twenty-one. J. Bone Joint Surg. A 52, 411–423 (1970).Google Scholar
  15. 15.
    Muggia, F. M., Louie, A. C.: Five years of adjuvant treatment of osteosarcoma: more questions than answers. Cancer Treat. Rep. 62, 301–305 (1978).PubMedGoogle Scholar
  16. 16.
    Pratt, C. B., Rivera, G., Shanks, E., Mahesh Kumar, A. P., Green, A. A., George, S.: Combination chemotherapy for osteosarcoma. Cancer Treat. Rep. 62, 251–257 (1978).PubMedGoogle Scholar
  17. 17.
    Pratt, C. B., Roberts, D., Shanks, E., Loehr, E.: Clinical trials and pharmacokinetics of intermittent highdose methotrexate-leucovorin rescue for children with malignant tumors. Cancer Res. 34, 3326–3331 (1974).PubMedGoogle Scholar
  18. 18.
    Pratt, C. B., Shanks, E. C.: Doxorubicin in treatment of malignant solid tumors in children. Am. J. Dis. Child. 127, 534–536 (1974).PubMedGoogle Scholar
  19. 19.
    Rab, G. T., Ivins, J. C., Childs, D. S. (Jr.), Cupps, R. E., Pritchard, D. J.: Elective whole lunirradiation in the treatment of osteogenic sarcoma. Cancer 38, 939–942 (1976).PubMedCrossRefGoogle Scholar
  20. 20.
    Rosen, G., Marcove, R. C., Caparros, B., Cahill, L., Huvos, A. G.: Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer (in press) (1978).Google Scholar
  21. 21.
    Rosen, G., Suwansirikul, S., Kwon, C.: Highdose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma. Cancer 33, 1151–1163 (1974).PubMedCrossRefGoogle Scholar
  22. 22.
    Sutow, W. W.: Perspectives in the management of osteosarcoma and rhabdomyosarcoma in children. Management of primary bone and soft tissue tumors, pp. 25–34, Year book medical publishers, Chicago, 1977.Google Scholar
  23. 23.
    Sutow, W. W., Gehan, E. A., Dyment, P. G., Vietti, T., Miale, T.: Multidrug adjuvant chemotherapy for osteosarcoma: Interim Report of the Southwest Oncology Group Studies. Cancer Treat. Rep. 62, 265–269 (1978).PubMedGoogle Scholar
  24. 24.
    Sutow, W. W., Gehan, E. A., Vietti, T. J., Frias, A. E., Dyment, P. G.: Multidrug chemotherapy in primary treatment of osteosarcoma. J. Bone Joint Surg. A 58, 629–633 (1976).Google Scholar
  25. 25.
    Sutow, W. W., Sullivan, M. P., Fernbach, D. J.: Adjuvant chemotherapy in primary treatment of osteogenic sarcoma. Proc. Am. Assoc. Cancer Res. 15, 20 (Abs.) (1974).Google Scholar
  26. 26.
    Sutow, W. W., Sullivan, M. P., Fernbach, D. J., Gangir, A George, S. L.: Adjuvant chemotherapy in primary treatment of osteogenic sarcoma. Cancer 36, 1598–1602 (1975).PubMedCrossRefGoogle Scholar
  27. 27.
    Taylor, W. F., Ivins, J. C., Dahlin, J. V., Pritchard, D. J.: Osteogenic sarcoma experience at Mayo Clinic, 1963–1974. Immunotherapy of cancer: present status of trials in man. Terry, W. D., Windhorst, D. (eds.), pp. 257–269. New York: Raven Press 1978.Google Scholar
  28. 28.
    Wilbur, J. R., Etcubanas, E., Long, T., Glatstein, E., Leavitt, T.: Drug therapy and irradiation in primary and metastatic osteogenic sarcoma. Proc. Am. Assoc. Cancer Res. 15, 188 (Abs.) (1974).Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1979

Authors and Affiliations

  • K. Breur
  • E. van der Schueren

There are no affiliations available

Personalised recommendations